PT
PAQ Therapeutics
2Press Releases
Latest Press Releases (2)
PAQ Therapeutics
PAQ Therapeutics to Present First Clinical Data for PT0253, a Selective KRAS G12D Degrader, in Late-Breaking Oral Presentation at the 2026 EORTC-NCI-AACR Symposium
BURLINGTON, Mass., Nov. 3, 2026

